Science
Mechanism of Action
CBD functions by modulating the cutaneous endocannabinoid system (ECS), primarily through the inhibition of anandamide degradation and interaction with CB1/CB2 receptors. Beyond the ECS, it activates TRPV1 to manage sensitivity and PPAR-γ to dampen inflammatory pathways, while concurrently suppressing sebocyte proliferation to balance oily skin.
Research
Clinical Evidence
High confidence1%
Key findings
- 01 Demonstrated significant reduction in epidermal thickness and PASI scores via the JAK2–STAT3 pathway (2024).
- 02 In vitro human sebocyte studies confirmed anti-lipogenic and anti-proliferative effects suitable for acne management (2014).
- 03 Keratinocyte and fibroblast trials showed upregulated skin regenerative genes (TGF-β, VEGF) and collagen production at micro-concentrations (2023).
Transparency
Dusting Analysis
Due to its high cost and marketing appeal, CBD is frequently 'dusted' at symbolic levels. For therapeutic anti-inflammatory or anti-acne results, concentrations should ideally reach 0.1% to 1.0%.
The Formula
Formulation
Stability
Highly prone to oxidation and light-induced degradation. It may cyclize into THC in highly acidic environments (pH < 4.0) or degrade into hydroxyquinones in alkaline conditions (pH > 7.0).
Synergies
- Squalane
- Tocopherol
- Linoleic Acid
- Terpenes
Conflicts
- Alkaline environments
- Strong oxidizing agents
- High heat
- UV radiation
Safety
Safety Profile
SCCS preliminary guidance (2025) suggests a safety limit of 0.19% for dermal applications with a strict 0.00025% THC impurity cap.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A sophisticated, multi-targeted bioactive that excels in calming reactive skin and regulating lipid production when stabilized correctly.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources